From cell cycle regulation to angiogenesis: Dialogue between the basic and clinical sciences

Journal of Cellular Physiology

Volumn 179, Issue 2, 1999, Pages 233-236

  Stiegler, Peter ^a,b   Lotan, Reuben ^c   Giordano, Antonio ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; CYTOKINE; HISTONE; HISTONE DEACETYLASE; PROTEIN KINASE B; RETINOID; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0032912175     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199905)179:2<233::AID-JCP14>3.0.CO;2-N     Document Type: Article

References (24)

1. Dong Z, Yang X, Fidler IJ. 1997. Neutralization of endogenous interferon-beta increases the efficiency of adenoviral vector-mediated gene transduction. J Interferon Cytokine Res 17:401-407.
2. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H. 1992. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825-1831.
3. Giordano A, Rustum YM, Wenner CE. 1998. Cell cycle: targets for diagnosis and therapy: tumor suppressor genes and cell cycle progression in cancer. J Cell Biochem 70:1-7.
4. Grant PA, Sterner DE, Duggan LJ, Workman JL, Berger SL. 1998. The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes. Trends Cell Biol 8:193-197.
5. Harvat BL, Wang A, Seth P, Jetten AM. 1998. Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. J Cell Sci 111: 1185-1196.
6. Hatva E, Bohling T, Jaaskelainen J, Persico MG, Haltia M, Alitalo K. 1996. Vascular growth factors and receptors in capillary hemangio-blastomas and hemangiopericytomas. Am J Pathol 148:763-775.
7. Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K, Giordano A. 1998. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. J Natl Cancer Inst 90:1451-1460.
8. Huang L, Zhang W, Roth SY. 1997. Amino termini of histones H3 and H4 are required for a1-alpha2 repression in yeast. Mol Cell Biol 17:6555-6562.
9. Iruela-Arispe ML, Dvorak HF. 1997. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 78:672-677.
10. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB. 1996. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci USA 93:9160-9165.
11. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191.
12. Kastner P, Mark M, Chambon P. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
13. Khuri FR, Lippman SM, Spitz MR, Lotan R, Hong WK. 1997. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst 89:199-211.
14. Levy-Strumpf N, Deiss LP, Berissi H, Kimchi A. 1997. DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death. Mol Cell Biol 17:1615-1625.
15. Lin T, Brunner T, Tietz B, Madsen J, Bonfoco E, Reaves M, Huflejt M, Green DR. 1998. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease. J Clin Invest 101:570-577.
16. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev 11:1479-1492.
17. Mathias S, Pena LA, Kolesnick RN. 1998. Signal transduction of stress via ceramide. Biochem J 335:465-480.
18. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK. 1996. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2:992-997.
19. Okada F, Rak JW, Croix BS, Lieubeau B, Kaya M, Roncari L, Shirasawa S, Sasazuki T, Kerbel RS. 1998. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA 95:3609-3614.
20. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr. 1998. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124-133 (see comments).
21. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW. 1997. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91:209-219 (see comments).
22. Tahara E. 1998. Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection. Exp Toxicol Pathol 50:375-378.
23. Xie B, Laouar A, Huberman E. 1998. Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha5 beta1 integrin in HL-60 cells. J Biol Chem 273:11583-11588.
24. Zhu X, Assoian RK. 1995. Integrin-dependent activation of MAP kinase: a link to shape-dependent cell proliferation. Mol Biol Cell 6:273-282 (published erratum appears in Mol Biol Cell 7:1001).